Crossmark

THC, CBD, and Anxiety: a Review of Recent Findings on the Anxiolytic and Anxiogenic Effects of Cannabis’ Primary Cannabinoids

Published Online: 2022-10-24

Authors

Lichenstein, Sarah D. https://orcid.org/0000-0002-2978-991X
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (K08DA051667)

Women's Health Research at Yale (1084)
License Information

Text and Data Mining valid from 2022-10-24

Version of Record valid from 2022-10-24
More Information

Article History

Accepted: 11 October 2022

First Online: 24 October 2022

Declarations

:

: The author declares no competing interests.

Document is current